We're at odds because you are taking 2 large trials that were designed to test 2 doses and suggesting one dose might be fine w/o sufficient data. The point estimate of 52% has a lower 95% CI of <30%. After masks, aerosols, etc, the last thing the public needs is more confusion.
-
-
"While we know that the single dose can protect against disease" seems like a strong statement - these were post hoc analyses, right? Your piece doesn't help any reader understand why post hoc analyses are problematic.
-
This Tweet is unavailable.
- Show replies
New conversation -
-
-
Yes it does need attn. No one I've seen is arguing otherwise. But as I said, preventing misinfo 1 impt thing & should've been the focus for such a layperson forum... 1/
-
...not discussing trial design/sci conjecture still being worked out, for prompting debate in a non-expert forum at time when misinfo already big issue. I stand by my 1st pt: your choice of forum was inappropriate for this topic as you discussed. 2/
- Show replies
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.